» Articles » PMID: 21491338

The Psychological Impact of Facial Changes in Scleroderma

Overview
Publisher Routledge
Date 2011 Apr 15
PMID 21491338
Citations 23
Authors
Affiliations
Soon will be listed here.
Abstract

The physical disabilities associated with scleroderma are well known but the psychological impact of the condition has received less attention. Few studies have examined appearance related issues, most notably of the face. The aim of this study is to evaluate the psychological impact of facial, aesthetic and functional changes in scleroderma. One hundred seventy-one patients with a clinical diagnosis of scleroderma were recruited into the study. Digital photographs were objectively graded into groups based on severity of disfigurement as judged by an observer. Facial movement was recorded using a modified House-Brackmann Grading Scale. Psychological evaluation comprised the Derriford Appearance Scale short-form (DAS), the Noticeability and Worry score and the Hospital Anxiety and Depression Scale (HADS). Severity of disfigurement predicted decreased mouth opening, the extent to which participants judged their appearance as noticeable to others, and the level of appearance-related concern as measured by the DAS24. There was an inverse relationship with age. Facial changes were ranked as the most worrying aspect of the condition. This study shows facial disfigurement impacts on patient with scleroderma independent of functional changes related to systemic disease. The major difficulty is with the perceived noticeably of the condition to other people and the resulting self-consciousness in social encounters.

Citing Articles

Perception of aesthetic impairment in patients with systemic sclerosis determined using a semi-quantitative scale and its association with disease characteristics.

Farhat M, Guerreschi P, Morell-Dubois S, Deken V, Labreuche J, Sanges S J Scleroderma Relat Disord. 2024; 9(2):124-133.

PMID: 38910601 PMC: 11188849. DOI: 10.1177/23971983241231620.


Clinician and patient experiences of managing and living with oral and dental manifestations of scleroderma: A scoping review.

Mills T, Price E, Aggarwal V, Del Galdo F, Walker L J Scleroderma Relat Disord. 2024; 9(2):86-98.

PMID: 38910600 PMC: 11188842. DOI: 10.1177/23971983231193515.


Exploring Anti-Fibrotic Effects of Adipose-Derived Stem Cells: Transcriptome Analysis upon Fibrotic, Inflammatory, and Hypoxic Conditioning.

Frommer M, Langridge B, Beedie A, Jasionowska S, Awad L, Denton C Cells. 2024; 13(8.

PMID: 38667308 PMC: 11049044. DOI: 10.3390/cells13080693.


Diagnosing and Managing Linear Scleroderma in a Low-Resource Setting.

Luch S, Men P, Fischer G, Wu A Case Rep Pediatr. 2023; 2023:3918638.

PMID: 37636244 PMC: 10449588. DOI: 10.1155/2023/3918638.


Single-Cell Analysis of ADSC Interactions with Fibroblasts and Endothelial Cells in Scleroderma Skin.

Frommer M, Langridge B, Awad L, Jasionowska S, Denton C, Abraham D Cells. 2023; 12(13).

PMID: 37443817 PMC: 10341100. DOI: 10.3390/cells12131784.